|
Symbol Name ID |
Cmya5
cardiomyopathy associated 5 MGI:1923719 |
| Age | E10.5 | E12.5 | E15.5 | E17.5 | P |
| Immunohistochemistry (section) | 1 | ||||
| In situ RNA (section) | 1 | 1 | 1 | 1 | |
| Northern blot | 1 | ||||
| RT-PCR | 3 | ||||
| cDNA clones | 1 |
| Cmya5 cardiomyopathy associated 5 (Synonyms: 2310076E16Rik, 2310076E21Rik, Myospryn) | |
| Results | Reference |
| 8* | J:110295 Durham JT, Brand OM, Arnold M, Reynolds JG, Muthukumar L, Weiler H, Richardson JA, Naya FJ, Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein. J Biol Chem. 2006 Mar 10;281(10):6841-9 |
| 1 | J:307828 Farrell E, Armstrong AE, Grimes AC, Naya FJ, de Lange WJ, Ralphe JC, Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling. Front Physiol. 2018;9:1442 |
| 1* | J:281175 Yorgan TA, Peters S, Amling M, Schinke T, Osteoblast-specific expression of Panx3 is dispensable for postnatal bone remodeling. Bone. 2019 Oct;127:155-163 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||